BIO-TECHNE Corp Public Float
BIO-TECHNE Corp (TECH) had Public Float of $9.10 billion as of 2025-12-31, per its 10-K filed 2026-08-24.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-08-24
- 2025-12-31: Entity Public Float $9.10B.
- 2024-12-31: Entity Public Float $11.40B.
- 2023-12-31: Entity Public Float $12.10B.
- 2022-12-31: Entity Public Float $13.00B.
| Period end | Entity Public Float |
|---|---|
| 2025-12-31 | $9.10B 10-K · filed 2026-08-24 |
| 2024-12-31 | $11.40B 10-K · filed 2025-08-22 |
| 2023-12-31 | $12.10B 10-K · filed 2024-08-22 |
| 2022-12-31 | $13.00B 10-K · filed 2023-08-23 |
| 2021-12-31 | $20.30B 10-K · filed 2022-08-24 |
| 2020-12-31 | $12.40B 10-K · filed 2021-08-25 |
| 2019-12-31 | $8.40B 10-K · filed 2020-08-26 |
| 2018-12-31 | $5.50B 10-K/A · filed 2019-11-06 |
| 2017-12-31 | $3.40B 10-K · filed 2018-08-27 |
| 2016-12-31 | $3.80B 10-K · filed 2017-09-07 |
| 2015-12-31 | $3.30B 10-K · filed 2016-08-29 |
| 2014-12-31 | $3.40B 10-K · filed 2015-08-31 |
| 2013-12-31 | $2.70B 10-K · filed 2014-08-29 |
| 2012-12-31 | $2.20B 10-K · filed 2013-08-29 |
| 2011-12-31 | $2.00B 10-K · filed 2012-08-29 |
| 2010-12-31 | $1.90B 10-K · filed 2011-08-29 |
| 2009-12-31 | $1.90B 10-Q · filed 2011-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |